692 results on '"Rowin, Ethan J."'
Search Results
2. Letter by Maron et al Regarding Article, “Sudden Cardiac Death in National Collegiate Athletic Association Athletes”
3. Percutaneous left atrial appendage closure for stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation
4. Identification of high-risk imaging features in hypertrophic cardiomyopathy using electrocardiography: A deep-learning approach
5. Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023
6. The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy
7. Extended Ambulatory ECG Monitoring Enhances Identification of Higher-Risk Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy
8. Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy
9. Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity
10. Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction
11. Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective
12. How common is hypertrophic cardiomyopathy… really?: Disease prevalence revisited 27 years after CARDIA
13. Evidence of Advanced Pulmonary Vascular Remodeling in Obstructive Hypertrophic Cardiomyopathy With Pulmonary Hypertension
14. Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy
15. Abstract 17053: Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Mortality in Hypertrophic Cardiomyopathy: A Retrospective Study
16. Abstract 16842: Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
17. Abstract 16793: The Impact of Late Gadolinium Enhancement on Sudden Death Risk Stratification in Older Patients With Hypertrophic Cardiomyopathy
18. Spontaneous Migration of Ventriculoperitoneal Shunt Into the Right Heart and Pulmonary Vasculature
19. Deformation-encoding Deep Learning Transformer for High-Frame-Rate Cardiac Cine MRI
20. Changing Demographics in Hypertrophic Cardiomyopathy and Implications for Management: Clinical Research
21. Altered intercellular communication and extracellular matrix signaling as a potential disease mechanism in human hypertrophic cardiomyopathy
22. Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
23. Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy
24. Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy
25. Importance of newer cardiac magnetic resonance–based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study
26. Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review
27. Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review
28. Precision Medicine for All?
29. Maintenance of Subcutaneous Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy Patients With Iatrogenic Left Bundle‐Branch Block After Septal Myectomy
30. Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Mortality in Hypertrophic Cardiomyopathy
31. Hypertrophic Cardiomyopathy
32. Identification of Transthyretin Cardiac Amyloidosis Among Patients Previously Diagnosed With Hypertrophic Cardiomyopathy
33. Usefulness of Global Longitudinal Strain to Predict Heart Failure Progression in Patients With Nonobstructive Hypertrophic Cardiomyopathy
34. Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator
35. Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices
36. Abstract 14304: Does QRS Fragmentation Have a Role in Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy?
37. Abstract 13383: Is Genotype Negative Hypertrophic Cardiomyopathy Really Benign? The Increased Risk of Sudden Death and Advanced Heart Failure in the Absence of Pathogenic Sarcomere Mutations
38. Abstract 13312: Can the Extent of Late Gadolinium Enhancement on Cardiac Magnetic Resonance Be Predicted by the 12-Lead Electrocardiogram?
39. Abstract 11009: A Novel Patient-Patient Network Medicine Approach to Refine Hypertrophic Cardiomyopathy Subgrouping: Implications for Risk Stratification
40. Abstract 10951: Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: A Meta-Analysis
41. Prediction and Prevention of Sudden Death in Young Patients (
42. Hypertrophic Cardiomyopathy and Sudden Death Initially Identified at Autopsy
43. Adult Monozygotic Twins With Hypertrophic Cardiomyopathy and Identical Disease Expression and Clinical Course
44. Single Coil Implantable Cardioverter Defibrillator Leads in Patients With Hypertrophic Cardiomyopathy
45. Hypertrophic Cardiomyopathy in “Real-World” Community Cardiology Practice
46. Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy
47. Assessing the impact of atrial fibrillation on symptoms and quality of life in hypertrophic cardiomyopathy
48. Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
49. Impact of Effective Management Strategies on Patients With the Most Extreme Phenotypic Expression of Hypertrophic Cardiomyopathy
50. Safety, Side Effects and Relative Efficacy of Medications for Rhythm Control of Atrial Fibrillation in Hypertrophic Cardiomyopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.